<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231023059826N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-04-07</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>The impact of home visit-based diabetes self-management education (DSME)</public_title>
      <acronym></acronym>
      <scientific_title>The impact of home visit-based diabetes self-management education (DSME) on glycemic control in children and adolescents with diabetes</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-10-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>108</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/73667</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Health service research, Other design features: This study will be conducted in two quantitative and qualitative phases. After the completion of the quantitative phase (clinical trial), the qualitative phase of the study will be conducted, Randomization description: Eligible patients enrolled from the pediatric diabetes clinic will be allocated to the intervention and control groups using block randomization with 6-subject blocks. Given the total sample size of 108 participants in this study, 18 blocks of 6 subjects will be utilized. The unit of randomization will be individual patients, and each patient will be randomly assigned to a group based on a sequence generated by Random Allocation Software (RAS).
The random sequence generation will follow a sequential process until the completion of sampling. Participants will be allocated to their respective groups in the order of their enrollment into the study, using randomly permuted blocks.
Allocation concealment will be implemented via the SNOSE method (Sequentially Numbered, Opaque, Sealed Envelopes). For this purpose, based on the predetermined sample size, envelopes will be prepared. Each randomly generated sequence will be recorded on a card, and these cards will be sealed inside numbered envelopes in sequential order. As patients are enrolled, the envelopes will be opened one by one to reveal their assigned group.
Blinding will be applied to the statistical analyst to ensure unbiased outcome assessment, Blinding description: The laboratory personnel or the outcome assessor, who measures the metabolic indicators in question, will be unaware of which patients are in the test or control group (blinding of outcome assessor). Also, the person who performs the data analysis will not know which group the patients are in. Therefore, this study is considered a "Single-Blind Randomised Controlled Trial".</study_design>
      <phase>N/A</phase>
      <hc_freetext>type 1 diabetes.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In this study, the intervention for each patient will be conducted over a period of 3 months, comprising 3 to 4 home visit sessions, along with daily follow-up through phone calls and WhatsApp messaging platform.The implementation method will be in accordance with the ADCES7 model, which encompasses the seven key behavioral guidelines established by the American Association of Diabetes Care &amp; Education Specialists (ADCES) and includes the areas of healthy coping, healthy eating, being active, taking medication, monitoring, problem solving, and reducing risks.Thus, in the first training session held at the home of each patient, the patient's condition will be examined based on each of the seven areas, the patient's weaknesses and strengths will be identified in each of the areas, and After determining the educational needs of each patient, the necessary training will be provided according to the relevant instructions (according to the guidelines). For example, in the field of healthy eating, the nutritional pattern of the patient and family, the knowledge and skills of the patient (and the main caregiver) about food groups, the effect of different foods on blood sugar, sources of carbohydrates, amounts of carbohydrates in foods, how to count carbohydrates, nutritional information labels of different foods, food substitutes, deciding on food choices in the outdoor environment and many other things will be examined according to the relevant guidelines in the field of healthy eating, Then, the necessary training will be provided based on the patient's needs in that area, according to the relevant instructions (Adces7 self care behaviour).In the field of taking medication, the patient's knowledge and skills about the name of the drug (insulin), the mechanism of action, the peak effect, the best time of use, possible side effects, missed dose, how to store the drug, how to properly inject insulin, the best places for Injections, side effects of unprincipled injections, maintaining safety points and many other cases will be examined and the necessary training will be provided based on the patient's needs in that area, according to the relevant instructions.This educational process will continue in the next sessions and until the completion of training in all areas of being active, monitoring, problem solving, reducing risks and healthy coping. In this way, trainings will be completed in all seven areas of diabetes self-management, according to the instructions of the Association of Diabetes Care and Education Specialists. Intervention 2: Control Group: Patients in the control group will receive routine services within the healthcare delivery system. In this clinic, patients are typically visited every three months by a pediatric endocrinologist, and when necessary, they are referred to the nutritionists and psychologists stationed at the clinic for further training. In contrast, patients in the intervention group will receive diabetes self-management education for a duration of 3 months, consisting of 1 session per week or biweekly, totaling 3 to 4 personalized sessions conducted exclusively in the patient's home, In accordance with the guidelines of the American Association of Diabetes Care and Education Specialists (ADCES).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Information regarding the primary and secondary outcomes of the participants will be provided upon the researchers’ request.

When:
Access to the data will begin after the publication of the articles resulting from the present project.

To whom:
The data will be made available to researchers in scientific and academic institutions upon request.

Conditions:
If a valid confirmation from a scientific or academic institution is provided, along with a statement indicating that the data will be used solely for scientific research, the data will be made available to the researchers.

Where to obtain:
Applicants can request the data through the email of the article’s authors.
torabik@sums.ac.ir
kianiam@sums.ac.ir

How to obtain:
If the confidentiality of the participants’ information in the study is ensured, the data will be immediately provided to the researchers via email.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Amin Kiani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Zand St., Namazi Sq., School of Nursing and Midwifery, Shiraz, Iran.</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>71936-13119</zip>
        <telephone>+98 71 3647 4256</telephone>
        <email>uniqamin@gmail.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Camellia Torabizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Zand St., Namazi Sq., School of Nursing and Midwifery, Shiraz, Iran.</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>71936-13119</zip>
        <telephone>+98 71 3647 4256</telephone>
        <email>torabik@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Be willing to participate in the study.
Reside in the city where the study is conducted.
The patient and the primary caregiver must be able to speak, read, and write in Persian.
The patient’s age should be between 8 and 16 years.
Have a history of type 1 diabetes for at least one year.
Have a history of poor glycemic control, with glycated hemoglobin (HbA1c) above 8% in the past year.
No family members of the patient should have type 1 diabetes.
The patient and the primary caregiver should not have physical disabilities or cognitive, hearing, and visual impairments according to their own statements.
Should not have participated in similar studies in the past six months.
Should not have other metabolic, chronic, or incurable diseases.
The patient and the primary caregiver should not have mental illnesses and should not be taking psychiatric medications.
Should not be taking any medications other than those used for diabetes, such as steroids.
The primary caregivers should not be employed in health-related professions.</inclusion_criteria>
      <agemin>8 years</agemin>
      <agemax>16 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The death of the patient or the primary caregiver occurs in the family.
The patient and the caregiver do not attend the sessions (miss at least two sessions in one month).
The patient or the primary caregiver is diagnosed with any incurable physical or mental illness during the study period.
Any severe physical or emotional crisis occurs for the patient during the study period.
The questionnaires used in the study are completed incompletely.
Participates in similar educational sessions.
The primary caregiver of the patient in the family is changed for any reason.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E10</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>E10 Type 1 diabetes mellitus</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In this study, the intervention for each patient will be conducted over a period of 3 months, comprising 3 to 4 home visit sessions, along with daily follow-up through phone calls and WhatsApp messaging platform.The implementation method will be in accordance with the ADCES7 model, which encompasses the seven key behavioral guidelines established by the American Association of Diabetes Care &amp; Education Specialists (ADCES) and includes the areas of healthy coping, healthy eating, being active, taking medication, monitoring, problem solving, and reducing risks.Thus, in the first training session held at the home of each patient, the patient's condition will be examined based on each of the seven areas, the patient's weaknesses and strengths will be identified in each of the areas, and After determining the educational needs of each patient, the necessary training will be provided according to the relevant instructions (according to the guidelines). For example, in the field of healthy eating, the nutritional pattern of the patient and family, the knowledge and skills of the patient (and the main caregiver) about food groups, the effect of different foods on blood sugar, sources of carbohydrates, amounts of carbohydrates in foods, how to count carbohydrates, nutritional information labels of different foods, food substitutes, deciding on food choices in the outdoor environment and many other things will be examined according to the relevant guidelines in the field of healthy eating, Then, the necessary training will be provided based on the patient's needs in that area, according to the relevant instructions (Adces7 self care behaviour).In the field of taking medication, the patient's knowledge and skills about the name of the drug (insulin), the mechanism of action, the peak effect, the best time of use, possible side effects, missed dose, how to store the drug, how to properly inject insulin, the best places for Injections, side effects of unprincipled injections, maintaining safety points and many other cases will be examined and the necessary training will be provided based on the patient's needs in that area, according to the relevant instructions.This educational process will continue in the next sessions and until the completion of training in all areas of being active, monitoring, problem solving, reducing risks and healthy coping. In this way, trainings will be completed in all seven areas of diabetes self-management, according to the instructions of the Association of Diabetes Care and Education Specialists.</i_keyword>
      <i_keyword>Control Group: Patients in the control group will receive routine services within the healthcare delivery system. In this clinic, patients are typically visited every three months by a pediatric endocrinologist, and when necessary, they are referred to the nutritionists and psychologists stationed at the clinic for further training. In contrast, patients in the intervention group will receive diabetes self-management education for a duration of 3 months, consisting of 1 session per week or biweekly, totaling 3 to 4 personalized sessions conducted exclusively in the patient's home, In accordance with the guidelines of the American Association of Diabetes Care and Education Specialists (ADCES).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Glycosylated hemoglobin: comparison of the average "glycosylated hemoglobin percentage value" before and after the intervention, between the two test and control groups. Timepoint: Before the start of the intervention, after the intervention, 3 and 6 months after the intervention. Method of measurement: "High performance liquid chromatography" method will be used to measure glycosylated hemoglobin.</prim_outcome>
      <prim_outcome>Lipid profile: Comparison of the average "lipid profile" before and after the intervention, between the two test and control groups. Timepoint: Before the start of the intervention, after the intervention, 3 and 6 months after the intervention. Method of measurement: In order to measure the "lipid profile" the "enzymatic colorimetry" method will be used.</prim_outcome>
      <prim_outcome>Knowledge scores: Comparison of the average "Diabetes Self-Management Knowledge Scores" before and after the intervention, between the two test and control groups. Timepoint: Before the start of the intervention, after the intervention, 3 and 6 months after the intervention. Method of measurement: Knowledge assessment questionnaire for children/adolescents with diabetes ( M-WIKAD).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Frequency of self-monitoring of blood sugar: Comparison of the average frequency of "self-monitoring of blood sugar" before and after the intervention, between the test and control groups. Timepoint: Before the start of the intervention, after the intervention, 3 and 6 months after the intervention. Method of measurement: time diary : The tool for recording activity time and events, this tool includes tables about the frequency of self-monitoring of blood sugar, the duration of exercise and events such as the number of missed doses of insulin, the frequency of hypoglycemia َand hyperglycemia, which are recorded on a daily basis.</sec_outcome>
      <sec_outcome>Quality of life: comparing the average scores of "quality of life" before and after the intervention, between the two test and control groups. Timepoint: Before the start of the intervention, after the intervention, 3 and 6 months after the intervention. Method of measurement: PedsQL™ 4.0 Pediatric Quality of Life Inventory.</sec_outcome>
      <sec_outcome>Missed dose of insulin frequency : Comparison of the average frequency of "missed dose of insulin" before and after the intervention between the test and control groups. Timepoint: Before the start of the intervention, after the intervention, 3 and 6 months after the intervention. Method of measurement: time diary : The tool for recording activity time and events, this tool includes tables about the frequency of self-monitoring of blood sugar, the duration of exercise and events such as the number of missed doses of insulin, the frequency of hypoglycemia َand hyperglycemia, which are recorded on a daily basis.</sec_outcome>
      <sec_outcome>The average duration of exercise per week: comparison of the average "duration of exercise per week" before and after the intervention between the two test and control groups. Timepoint: Before the start of the intervention, after the intervention, 3 and 6 months after the intervention. Method of measurement: time diary : The tool for recording activity time and events, this tool includes tables about the frequency of self-monitoring of blood sugar, the duration of exercise and events such as the number of missed doses of insulin, the frequency of hypoglycemia َand hyperglycemia, which are recorded on a daily basis.</sec_outcome>
      <sec_outcome>The average frequency of hypoglycemia in the week before and after the intervention between the two test and control groups. Timepoint: Before the start of the intervention, after the intervention, 3 and 6 months after the intervention. Method of measurement: time diary : The tool for recording activity time and events, this tool includes tables about the frequency of self-monitoring of blood sugar, the duration of exercise and events such as the number of missed doses of insulin, the frequency of hypoglycemia َand hyperglycemia, which are recorded on a daily basis.</sec_outcome>
      <sec_outcome>The average frequency of daily hyperglycemia before and after the intervention between the two test and control groups. Timepoint: Before the start of the intervention, after the intervention, 3 and 6 months after the intervention. Method of measurement: time diary : The tool for recording activity time and events, this tool includes tables about the frequency of self-monitoring of blood sugar, the duration of exercise and events such as the number of missed doses of insulin, the frequency of hypoglycemia َand hyperglycemia, which are recorded on a daily basis.</sec_outcome>
      <sec_outcome>The average number of hospitalizations due to diabetic ketoacidosis, before and after the intervention between the two experimental and control groups. Timepoint: Before the start of the intervention, after the intervention, 3 and 6 months after the intervention. Method of measurement: time diary : The tool for recording activity time and events, this tool includes tables about the frequency of self-monitoring of blood sugar, the duration of exercise and events such as the number of missed doses of insulin, the frequency of hypoglycemia َand hyperglycemia, which are recorded on a daily basis. Also, events such as hospitalization due to diabetic ketoacidosis can be recorded.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-04-20</approval_date>
        <contact_name>Research Ethics Committees of Schools of Nursing and Midwifery, Management and Medical Information s</contact_name>
        <contact_address>Faculty of Nursing and Midwifery of Hazrat Fatemeh, entrance of Namazi Hospital, Namazi Square, shiraz Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
